AG0038OW

51-48-9 | L-Thyroxine-[l-tyr-ring-13c6] hydrochloride

AG0038OW

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	51-48-9
Catalog Number	AG0038OW(AGN-PC-0WADMC)
Chemical Name	L-Thyroxine-[l-tyr-ring-13c6] hydrochloride
IUPAC Name	(2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid
InChI	InChI=1S/C15H11I4NO4/c16-8-4-7(5-9(17)13(8)21)24-14-10(18)1-6(2-11(14)19)3-12(20)15(22)23/h1-2,4-5,12,21H,3,20H2,(H,22,23)/t12-/m0/s1
InChI Key	XUIIKFGFIJCVMT-LBPRGKRZSA-N
MDL Number	MFCD00002595
Molecular Formula	C15H11I4NO4
Molecular Weight	776.8700
NSC Number	757434
SMILES	OC1=C(C=C(C=C1I)OC1=C(C=C(C[C@H](N)C(=O)O)C=C1I)I)I
UNII	Q51BO43MG4
Synonyms	3,5,3',5'-Tetraiodothyronine, Berlthyrox, Dexnon, Eferox, Eltroxin, Eltroxine, Euthyrox, Eutirox, L Thyrox, L Thyroxin beta, L Thyroxin Henning, L Thyroxine, L Thyroxine Roche, L-3,5,3',5'-Tetraiodothyronine, L-Thyrox, L-Thyroxin beta, L-Thyroxin Henning, L-Thyroxine, L-Thyroxine Roche, Lévothyrox, Levo T, Levo-T, Levothroid, Levothyroid, Levothyroxin Deladande, Levothyroxin Delalande, Levothyroxine, Levothyroxine Sodium, Levoxine, Levoxyl, Novothyral, Novothyrox, O-(4-Hydroxy-3,5-diiodophenyl) 3,5-diiodo-L-tyrosine, O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodotyrosine, Oroxine, Sodium Levothyroxine, Synthroid, Synthrox, T4 Thyroid Hormone, Thevier, Thyrax, Thyroid Hormone, T4, Thyroxin, Thyroxine, Tiroidine, Tiroxina Leo, Unithroid, L-thyroxine, levothyroxine, 51-48-9, thyroxine, thyroxin, Tetraiodothyronine, Thyrax, 3,3',5,5'-Tetraiodo-L-thyronine, Thyratabs, Thyreoideum, Thyroxinal, synthroid, Thyroxine iodine, Levothyroxin, (-)-Thyroxine, L-Thyroxin, 3,5,3',5'-Tetraiodo-L-thyronine, L-T4, Thyroxine (l), Levothyroxine sodium, levothroid, Levoxyl, DL-Thyroxin, t4, Thyroxine (VAN), eltroxin, 3,5,3',5'-Tetraiodothyronine, Laevothyroxinum, Tetramet, T4 (Hormone), Thyroxine I 125, L-3,5,3',5'-Tetraiodothyronine, Levothyroxinum (acid), Laevothyroxinum (acid), Thryroxine, l-, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-L-tyrosine, Forthyron (TN), Synthroid sodium, NSC 36397, Levothyroxinum, 3,3',5,5''-Tetraiodo-L-thyronine, CCRIS 6739, Henning, HSDB 3108, 3,5,3'5'-Tetraiodo-L-thyronine, THX, UNII-Q51BO43MG4, Prestwick_548, L-Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, 4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodo-L-phenylalanine, CHEBI:18332, O-(4-Hydroxy-3,5-diidophenyl)-3,5-diiodo-L-tyrosine, EINECS 200-101-1, 3-(4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)alanine, beta-((3,5-Diiodo-4-hydroxyphenoxy)-3,5-diiodophenyl)alanine, 3-[4-(4-Hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]-L-alanine, BRN 2228515, CHEMBL1624, O-(4-Hydroxy-3,5-diiodophenyl)-3,5-diiodotyrosine, (2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid, Q51BO43MG4, UNII-7U4LEE5872, XUIIKFGFIJCVMT-LBPRGKRZSA-N, MFCD00002595, C15H11I4NO4, NCGC00164336-01, CPD000059176, L-Thyroxine, 97+%, DSSTox_CID_3214, (2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]propanoic acid, DSSTox_RID_76927, DSSTox_GSID_23214, Thyroxine [BAN], Eutirox, Thyroxine, L-, L-Thryoxin, 7U4LEE5872, T4 levothyroxine, (S)-2-amino-3-(4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl)propanoic acid, LT4, SMR000059176, T44, Levothyroxine (BAN), 24486-40-6, Levothyroxine [INN:BAN], Synthroid (*Sodium salt*), (125I)T4, SR-01000759430, 2ceo, CAS-51-48-9, Levothyroxine Sodium (L-thyroxine), AK-40208, Thyroxine, labeled with iodine-125, Spectrum_001076, 1hk1, 1hk2, 1hk3, 1hk4, 1hk5, 1y0x, L-Thyroxine, free acid, SpecPlus_000871, Prestwick0_000403, Prestwick1_000403, Prestwick2_000403, Prestwick3_000403, Spectrum2_000573, Spectrum3_000611, Spectrum4_000128, Spectrum5_001500, Thyroxine, L- (8CI), bmse000923, Epitope ID:123889, T-3850, AC1L1L7K, BIDD:PXR0161, Levothroid (*Sodium salt*), SCHEMBL23098, BSPBio_000326, BSPBio_002142, KBioGR_000516, KBioSS_001556, MLS000028647, MLS002548901, DivK1c_006967, SPECTRUM1500774, SPBio_000386, SPBio_002265, BPBio1_000360, GTPL2635, DTXSID8023214, CTK2H7538, KBio1_001911, KBio2_001556, KBio2_004124, KBio2_006692, KBio3_001642, KS-00000HDI, HMS1569A08, HMS1921I06, HMS2090P18, HMS2092K12, HMS2096A08, HMS2233J18, HMS3259M11, HMS3713A08, L-Thyroxine, >=98% (HPLC), Pharmakon1600-01500774, ZINC3830993, Tox21_112101, Tox21_302156, BDBM50301375, CCG-38738, CT-230, GP9966, NSC757434, s2599, AKOS015905129, Tox21_112101_1, AC-7504, AM83594, AN-8921, CHM0030272, CS-1819, DB00451, NC00485, NSC-757434, SDCCGMLS-0066571.P001, 2-amino-3-[4-(4-hydroxy-3,5-diiodo-phenoxy)-3,5-diiodo-phenyl]-propanoic acid, 3,3'',5,5''-tetraiodo-L-thyronine, 3,5,3'',5''-tetraiodo-L-thyronine, NCGC00094852-03, NCGC00164336-02, NCGC00164336-03, NCGC00164336-05, NCGC00164336-06, NCGC00255368-01, AC-10465, AN-15421, BC630681, HY-18341, SAM002264651, SBI-0051608.P002, AB0010528, AB2000689, AX8015809, DB-006261, LS-158291, TR-031344, FT-0600821, ST24047479, SW196731-3, C01829, D08125, J10324, AB00052176-08, AB00052176_09, AB00052176_10, 002T595, SR-05000001567, SR-01000759430-2, SR-05000001567-1, BRD-K30685142-001-05-5, BRD-K30685142-001-08-9, Thyroxine (T4), IRMM(R) certified Reference Material, L-Thyroxine, powder, BioReagent, suitable for cell culture, UNII-QR0BV3BRIA component XUIIKFGFIJCVMT-LBPRGKRZSA-N, Levothyroxine, United States Pharmacopeia (USP) Reference Standard, Levothyroxine, Pharmaceutical Secondary Standard; Certified Reference Material, Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, labeled with iodine-125, L-Thyroxine (T4) solution, 100 mug/mL in methanol with 0.1N NH3, ampule of 1 mL, certified reference material, Euthyrox, Oroxine, Levothyrox, Novothyrox, Thyroxevan, Unithroid, D-Thyroxine, Laevoxin, Levolet, Berlthyrox, Levoxine, Levaxin, Thevier, Eferox, Letter, Levo-T, Thyroxin sodium, Thyroxine sodium, null, Thyro-Tabs, Levoroxine, Levothyroid, Novothyral, Thyronamin, Thyroxinique, Dathroid, Eltroxine, Forthyron, Soloxine, Synthrox, Thyradin, Thyrosit, Tiroidina, Tiroidine, Tirosint, Tyrosint, Leventa, Roxstan, Tetroid, Dexnon, Sodium thyroxin, Ro-thyroxine, Armour Thyroid, Guna-lympho, Sodium thyroxine, Tiroxina Leo, L Thyroxine, Thyradin S, L Thyroxin beta, L-Thyroxin beta, Thyroxine sodique, Sodium levothyroxine, L Thyrox, L-Thyrox, Sodium thyroxinate, Sodium l-thyroxin, L Thyroxine Roche, L-Thyroxine Roche, Levotiroxina sodica, Thyroxinum natricum, Levo T, Synthroid (TN), L-Thyroxine sodium, Sodium L-thyroxine, Sodium-L-thyroxine, levothyroxin natrium, levothyroxinnatrium-, Eltroxin (TN), Euthyrox (TN), L Thyroxin Henning, L-Thyroxin Henning, Levothyroxin-natrium, Eutirox (TN), Levaxin (TN), Levoxyl (TN), L-thyroxine (TN), Levothyroxine sodique, T4 Thyroid Hormone, Thyrax (TN), Thyrox (TN), Levothyroxine [INN], Levothyroxin Deladande, Levothyroxin Delalande, Levothyroxinum natricum, Thyroid Hormone, T4, L-Thyroxine sodium salt, Thyroxine, L-(8CI), silver(1+) sulfadiazinate, Thyroxine I 125 [USAN], D06RGG, Levothroid (*Sodiumsalt*), l-Thyroxine monosodium salt, Levothyroxine sodium hydrate, Levothyroxine sodium tablets, UNII-054I36CPMN, Levothyroxine Sodium [USAN], Levothyroxine sodium anhydrous, C15H11I4NO4.Na, levothyroxine sodium pentahydrate, CID5819, L-Thyroxine, 98% - 1G 1g, Levothyroxine Sodium [USAN:INN], Levotiroxina sodica [INN-Spanish], Levothyroxine sodique [INN-French], C15-H11-I4-N-O4.Na, EINECS 200-221-4, Levothyroxinum natricum [INN-Latin], 3,3',5,5"-Tetraiodo-L-thyronine, C15-H11-I4-N-O4, ACN-034091, CS-O-01770, NSC 259940, B2107, LT00440967, 4-14-00-02373 (Beilstein Handbook Reference), Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, A11669, 3,3',5,5'-Tetraiodo-L-thyronine, sodium salt, D013974, O-(4-Hydroxy-3,5-diiodophenyl) 3,5-diiodo-L-tyrosine, Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo- (9CI), (-)-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]alanine, 51-49-0, 55-03-8, L-Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, monosodium salt, (2R)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid, L-Tirosina, O-(4-hidroxi-3,5-diiodofenil)-3,5-diiodo-, sal de sodio (1:1), 22199-08-2, 6106-07-6, 7019-69-4, 7488-70-2,

Complexity	420
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	1
Defined Atom Stereocenter Count	1
Defined Bond Stereocenter Count	0
Exact Mass	776.687g/mol
Formal Charge	0
Heavy Atom Count	24
Hydrogen Bond Acceptor Count	5
Hydrogen Bond Donor Count	3
Isotope Atom Count	0
Molecular Weight	776.874g/mol
Monoisotopic Mass	776.687g/mol
Rotatable Bond Count	5
Topological Polar Surface Area	92.8A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0
XLogP3	2.4

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class	\N
Hazard statements	H315-H319-H335
Packing Group	\N
Precautionary statements	P261-P305+P351+P338
UN Code	\N

Certificate of Analysis

Lot Number